Malik AH, Yandrapalli S, Pemmasani G, et al. Pharmacotherapeutics for prevention of aortic root enlargement in Marfan Syndrome – a network meta-analysis of randomized controlled trials. Eur J Prev Cardiol. 2020; 27: 2187–2190.
2.
Kang YN, Chi SC, Wu MH, et al. The effects of losartan versus beta-blockers on cardiovascular protection in Marfan syndrome: a systematic review and meta-analysis. J Formos Med Assoc Taiwan yi zhi. 2020; 27: 1447–1450.
3.
Li L, Yamani N, Al-Naimat S, et al. Role of losartan in prevention of aortic dilatation in Marfan syndrome: a systematic review and meta-analysis. Eur J Prev Cardiol. 2020; 27: 1447–1450..
4.
ShoresJBergerKRMurphyEA, et al.Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med1994; 330: 1335–1341.
5.
Mullen M. Hot Line Session 5. In: European Society of Cardiology Congress, 25–29 August 2018, Munich.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
